Gastrointestinal epithelial barrier disorders

Gene: ADAM17

Amber List (moderate evidence)

ADAM17 (ADAM metallopeptidase domain 17)
EnsemblGeneIds (GRCh38): ENSG00000151694
EnsemblGeneIds (GRCh37): ENSG00000151694
OMIM: 603639, Gene2Phenotype
ADAM17 is in 7 panels

4 reviews

Olivia Niblock (Genomics England Curator)

Comment when marking as ready: This gene is being marked as ready, having been reviewed internally by the clinical team, by the curation team and by the expert reviewer. 25/07/2018
Created: 25 Jul 2018, 4:22 p.m.

Sarah Leigh (Genomics England Curator)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
?Inflammatory skin and bowel disease, neonatal, 1 614328

Ellen McDonagh (Genomics England Curator)

Comment on list classification: Green review from expert reviewer, and found in 2/4 original sources, though only one family report found for association with neonatal inflammatory bowel disease (a sister and brother with neonatal inflammatory skin and bowel lesions) - PMID: 22010916, after an extensive literature search. There is functional/mouse model evidence to support the association, and ADAM17 is known to have a role in controlling inflammation and tissue regeneration (PMID: 21752713).
Created: 12 Oct 2016, 8:54 a.m.

Neil shah (GOSH)

Green List (high evidence)

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Expert list
  • Eligibility statement prior genetic testing
  • Radboud University Medical Center, Nijmegen
  • UKGTN
Phenotypes
  • ?Inflammatory skin and bowel disease, neonatal, 1 614328
  • Gastrointestinal epithelial barrier disorders
  • Immunodeficiency 33, 300636
  • Immunodeficiency, isolated, 300584
  • ?Inflammatory skin and bowel disease, neonatal, 1, 614328
OMIM
603639
Clinvar variants
Variants in ADAM17
Penetrance
Complete
Panels with this gene

History Filter Activity

25 Jul 2018, Gel status: 2

Panel promoted to version 1.0

Olivia Niblock (Genomics England Curator)

Panel reviews have been assessed and internal clinical team opinion has been sought on this panel, particularly to rule out incidental findings. Panel has been revised through expert review, internal review and literature research. 25/07/2018

25 Jul 2018, Gel status: 2

Entity classified by Genomics England curator

Olivia Niblock (Genomics England Curator)

Gene: adam17 has been classified as Amber List (Moderate Evidence).

17 Apr 2018, Gel status: 2

Set penetrance

Olivia Niblock (Genomics England Curator)

Phenotypes for gene ADAM17 were set to ?Inflammatory skin and bowel disease, neonatal, 1 614328, Gastrointestinal epithelial barrier disorders, Immunodeficiency 33, 300636, Immunodeficiency, isolated, 300584, ?Inflammatory skin and bowel disease, neonatal, 1, 614328

17 Apr 2018, Gel status: 2

Set penetrance

Olivia Niblock (Genomics England Curator)

Phenotypes for gene ADAM17 were set to ?Inflammatory skin and bowel disease, neonatal, 1 614328, Gastrointestinal epithelial barrier disorders, Immunodeficiency 33, 300636, Immunodeficiency, isolated, 300584, ?Inflammatory skin and bowel disease, neonatal, 1, 614328

11 Aug 2017, Gel status: 2

Added New Source

Olivia Niblock (Genomics England Curator)

ADAM17 was added to Gastrointestinal epithelial barrier disorderspanel. Source: Expert list

26 Jan 2017, Gel status: 0

Created

Sarah Leigh (Genomics England Curator)

ADAM17 was created by sleigh

26 Jan 2017, Gel status: 2

Added New Source

Sarah Leigh (Genomics England Curator)

ADAM17 was added to Gastrointestinal epithelial barrier disorderspanel. Sources: Eligibility statement prior genetic testing,Radboud University Medical Center, Nijmegen,UKGTN